← Eichor
Condition: Warm Autoimmune Hemolytic Anemia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Warm Autoimmune Hemolytic Anemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia
EARLY_Phase 1 · 1 location(s) · The Second Hospital of Anhui Medical University · NCT07530380Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Phase 1/Phase 2 · 10 location(s) · CRISPR Therapeutics AG · NCT07549698Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (w
Phase 2 · 25 location(s) · Novartis Pharmaceuticals · NCT07039422OM336 in Autoimmune Cytopenias
Phase 1 · 3 location(s) · Lakefront Biotherapeutics West LLC · NCT07083960IASO-782 in Autoimmune Hematological Diseases
Phase 1 · 2 location(s) · Shanghai IASO Biotechnology Co., Ltd · NCT06534021National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07019038Sirolimus in the Treatment of Refractory/Relapsed wAIHA
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05925023A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Partici
Phase 3 · 95 location(s) · Sanofi · NCT07086976Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Diso
Phase 2 · 40 location(s) · Incyte Corporation · NCT07104565
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.